This program has concluded

Return to Classroom
Loading the player...

Information


Federal Policy - The Future of FDA and Cannabis Regulation


Exploring the road to Federal Food and Drug Administration regulation of medical cannabis products.

Amber Littlejohn, Esq., Of Counsel, Ice Miller LLP

Amber Littlejohn has served as a lawyer, strategist, and advocate for businesses in emerging markets for more than 15 years, providing government and business affairs services to businesses, nonprofit organizations, and lawmakers in regulated industries. She creates innovative legislative, regulatory, and public engagement strategies to access and grow markets, stabilize supply chains, and reduce crisis frequency and reach.

Named a Top Cannabis Lobbyist by Business Insider, Amber is a nationally recognized voice for the cannabis industry and related policy initiatives appearing regularly in national media outlets. She has testified before Congress on issues including small business capital access and cannabis legalization. She engages regularly with lawmakers and regulators at all levels of government. Prior to her work in cannabis, she was a business owner, strategist, and advocate for specialty consumer packaged goods and consumer health products including dietary supplements and sports nutrition products. 

Prior to joining Ice Miller, Amber was president and chief strategic officer for a public affairs firm that served to provide solutions in the areas of legislative and regulatory policy development, as well as government and regulatory affairs. She has also served as policy counsel and a consultant for several organizations in Washington, D.C.

Patrick Goggin, Hoban Law Group

Earning an Environmental Law Certificate from Lewis and Clark Law School in Portland, Oregon, Mr. Goggin was admitted to the California Bar in 1996. Based in San Francisco, he served as co-counsel in the seminal HIA v. DEA cases in the early 2000s. Later, Mr. Goggin led the industry effort with Senator Mark Leno in 2013 to finally pass California’s Industrial Hemp Farming Act after three vetoes.

Mr. Goggin began working on medical cannabis regulation in San Francisco in 2005 when the City commenced its regulation of dispensaries. Since then, he has represented clients throughout Northern California on compliance issues and permitting of all facets of medical cannabis activity. He served on San Francisco’s Medical Cannabis Task Force from 2010-11.

Presently, Mr. Goggin sits on Vote Hemp’s board and is working to implement hemp research in California. He recently joined Hoban Law Group full-time and continues to advise clients on all forms of cannabis compliance. With a long history of litigating, Mr. Goggin is a trained mediator and has a respected reputation as a dispute resolution specialist.

Garrett Graff, Managing Attorney, Moye White LLP

A nationally recognized attorney, Garrett Graff specializes in the representation of both the marijuana and industrial hemp industries. Garrett’s practice involves corporate and M&A, real estate, regulatory/compliance, FDA/FTC compliance, intellectual property protection, and civil and commercial litigation. Garrett regularly counsels’ clients regarding corporate formation and structuring, M&A and business and real property assets, various corporate agreements, regulatory compliance as well as resolving and/or litigating commercial disputes. Related to marijuana businesses, Garrett represents numerous companies on matters including licensure, successfully obtaining licenses in numerous states in both competitive and non-competitive licensure processes. He also assists clients in general corporate matters, protecting intellectual property, establishing partnerships and joint ventures, and expanding clients’ footprints across multiple states and/or countries, along with regulatory compliance matters. As to industrial hemp businesses, Garrett represents companies across the country and world on matters including import/export, cultivation, processing and manufacturing, distribution, and navigating legislative and regulatory frameworks such as FDA regulation. He frequently works with federal, state and local authorities on policy and enforcement matters. Notably, Garrett represented hemp industry stakeholders against the DEA, before the Ninth Circuit Court of Appeals, in confirming the Farm Bill’s hemp provisions pre-empt DEA authority and the CSA. He also regularly works with stakeholders in drafting model legislative and regulatory policy. Garrett also serves on the board of the Colorado chapter of the Hemp Industries Association. Garrett has testified in judicial proceedings related to hemp regulatory matters and frequently speaks in many forums — conferences, symposiums, and other events — regarding various issues concerning marijuana and industrial hemp law.


PLEASE UPGRADE TO A MODERN BROWSER

FOR A BETTER EXPERIENCE. KEEP YOUR BROWSER UP TO DATE
Download Google Crome Browser Download Firefox Browser
CONTINUE FORWARD IN MY CURRENT BROWSER (Mozilla 0.0)
OK
Restart the Seminar
Restart Section